BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain ...

BrainsWay Ltd. BWAY recently announced an expansion of insurance coverage for its Deep TMS therapy in adolescent depression.

Brainsway ( ($BWAY) ) has provided an announcement. On December 22, 2025, BrainsWay Ltd. reported that Optum Behavioral Health, part of ...

Please provide your email address to receive an email when new articles are posted on . Deep TMS has received expanded indication for the treatment of major depressive disorder in patients aged 22 to ...

BrainsWay Ltd. (NASDAQ: BWAY) shares rocketed Monday. The Burlington, Mass.-based company, claiming to be a global leader in advanced noninvasive brain stimulation technologies, today announced that ...

Please provide your email address to receive an email when new articles are posted on . Transcranial magnetic stimulation targets the central executive network. 80% of patients responded by 20 ...

BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain ...

BURLINGTON, Mass. and JERUSALEM, Jan. 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BWAY) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...

Moment of Clarity has published a new educational resource titled “How Deep TMS Therapy Works,” providing a comprehensive overview of transcranial magnetic stimulation (TMS) and its emerging role in ...

BrainsWay (BWAY) announced recent positive pilot data from an independent, third-party study conducted at Stanford University evaluating an accelerated protocol using the Company’s Deep Transcranial ...

BrainsWay has unveiled promising clinical data from a study showing that its Deep Transcranial Magnetic Stimulation therapy significantly reduces pain as well as symptoms of anxiety and depression in ...